1.20
price up icon5.26%   0.06
after-market 시간 외 거래: 1.20
loading
전일 마감가:
$1.14
열려 있는:
$1.1805
하루 거래량:
2,447
Relative Volume:
0.05
시가총액:
$13.89M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-2.2642
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
+4.35%
1개월 성능:
+8.11%
6개월 성능:
+11.11%
1년 성능:
-32.96%
1일 변동 폭
Value
$1.1805
$1.20
1주일 범위
Value
$1.1192
$1.20
52주 변동 폭
Value
$0.70
$2.44

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
명칭
Therapeuticsmd Inc
Name
전화
561-961-1900
Name
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
직원
1
Name
트위터
@TherapeuticsMD
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
TXMD's Discussions on Twitter

TXMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
TXMD
Therapeuticsmd Inc
1.20 13.19M 996.00K -6.09M -9.76M -0.53
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.45 67.31B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.74 45.95B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.75 43.35B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.58 18.68B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
305.61 13.44B 2.99B 1.21B 1.13B 25.06

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-08-07 다운그레이드 Jefferies Hold → Underperform
2020-05-19 다운그레이드 JP Morgan Overweight → Neutral
2019-12-02 개시 Guggenheim Buy
2019-10-17 개시 H.C. Wainwright Buy
2019-04-30 재개 Noble Capital Markets Outperform
2018-06-15 개시 JP Morgan Overweight
2017-09-08 개시 Morgan Stanley Equal-Weight
2017-07-11 업그레이드 Oppenheimer Perform → Outperform
2017-05-09 다운그레이드 Oppenheimer Outperform → Perform
2016-11-22 재개 Jefferies Buy
2016-11-22 개시 Oppenheimer Outperform
2016-11-07 재개 Guggenheim Buy
2016-04-04 개시 Goldman Buy
2015-12-08 재확인 Jefferies Buy
2015-12-08 재확인 Stifel Buy
2015-09-21 재확인 Jefferies Buy
2015-06-09 개시 Guggenheim Buy
2014-07-08 개시 FBR Capital Outperform
2014-04-17 재확인 Noble Financial Buy
2014-01-28 재확인 Noble Financial Buy
모두보기

Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스

pulisher
05:45 AM

Is TherapeuticsMD Inc. a good long term investmentExceptional trading performance - Autocar Professional

05:45 AM
pulisher
12:46 PM

TherapeuticsMD Inc. Stock Analysis and ForecastHigh-octane investment gains - Autocar Professional

12:46 PM
pulisher
12:01 PM

What drives TherapeuticsMD Inc. stock priceFree Consultation - Autocar Professional

12:01 PM
pulisher
03:37 AM

What analysts say about TherapeuticsMD Inc. stockHigh-yield capital appreciation - Autocar Professional

03:37 AM
pulisher
Jul 16, 2025

How TherapeuticsMD Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

TherapeuticsMD (NASDAQ:TXMD) Shares Down 0.8% – What’s Next? - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

What makes TherapeuticsMD Inc. stock price move sharplyIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why TherapeuticsMD Inc. stock attracts strong analyst attentionMinimized Risk Maximum Return - Newser

Jul 15, 2025
pulisher
Jun 01, 2025

Mayne Pharma Group Unit Seeks Over $11.5 Million in Damages in US Court Complaint Against TherapeuticsMD - marketscreener.com

Jun 01, 2025
pulisher
Jun 01, 2025

Mayne Pharma Files Legal Complaint Against TherapeuticsMD - TipRanks

Jun 01, 2025
pulisher
May 21, 2025

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World

May 21, 2025
pulisher
May 15, 2025

TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com - Defense World

May 15, 2025
pulisher
May 15, 2025

TherapeuticsMD Reports Improved Q1 2025 Results - TipRanks

May 15, 2025
pulisher
May 14, 2025

TherapeuticsMD Announces First Quarter 2025 Financial Results | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

TherapeuticsMD: Q1 Earnings Snapshot - CT Insider

May 14, 2025
pulisher
May 14, 2025

TherapeuticsMD Announces First Quarter 2025 Financial Results - BioSpace

May 14, 2025
pulisher
May 13, 2025

TherapeuticsMD Inc Reports Q1 2025 Results: EPS at -$0.06, Revenue Reaches $393K - GuruFocus

May 13, 2025
pulisher
May 13, 2025

TherapeuticsMD Reports Q1 2025 Financial Results - TipRanks

May 13, 2025
pulisher
May 13, 2025

TherapeuticsMD Q1 Operating Expenses USD 1.264 Million - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com - Defense World

May 12, 2025
pulisher
May 04, 2025

Today's Dead Cat Bounce Stock: TherapeuticsMD (TXMD) - TheStreet

May 04, 2025
pulisher
Apr 28, 2025

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 28, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Therapeuticsmd Inc (TXMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.31
price up icon 1.34%
$15.02
price up icon 0.60%
$9.37
price up icon 1.41%
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 1.32%
$133.66
price up icon 0.69%
$305.61
price up icon 2.59%
자본화:     |  볼륨(24시간):